<PAGE>
------------------------------
OMB APPROVAL
------------------------------
------------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden hours
per response . . . 14.90
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
CV Therapeutics, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
126667104
-------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [_]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
- ----------------------------
CUSIP No. 126667104 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BankAmerica Corporation
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF SHARES ---------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY OWNED
380,998
BY EACH REPORTING ---------------------------------------------------------
7 SOLE DISPOSITIVE POWER
PERSON WITH
-0-
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
304,686
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
380,998
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.5%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
HC
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2
<PAGE>
- ----------------------------
CUSIP No. 126667104 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON:
Bank of America NT&SA
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF SHARES ---------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY OWNED
380,998
BY EACH REPORTING ---------------------------------------------------------
7 SOLE DISPOSITIVE POWER
PERSON WITH
-0-
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
304,686
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
380,998
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.5%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
BK
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 3
<PAGE>
- ----------------------------
CUSIP No. 126667104 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON:
BankAmerica Ventures
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF SHARES ---------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY OWNED
304,686
BY EACH REPORTING ---------------------------------------------------------
7 SOLE DISPOSITIVE POWER
PERSON WITH
-0-
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
304,686
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
304,686
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.6%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 4
<PAGE>
- ----------------------------
CUSIP No. 126667104 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON:
BA Venture Partners II
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF SHARES ---------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY OWNED
30,468
BY EACH REPORTING ---------------------------------------------------------
7 SOLE DISPOSITIVE POWER
PERSON WITH
-0-
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
30,468
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,468
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 5
<PAGE>
Item 1 (a) Name of Issuer: CV Therapeutics, Inc.
(b) Address of Issuer's 3172 Porter Drive
Principal Executive Palo Alto, CA 94304
Offices:
Item 2 (a) Names of Person Filing: BankAmerica Corporation
("BAC")
Bank of America NT&SA
("BANTSA")
BankAmerica Ventures
("BAV")
BA Venture Partners II
("BAVPII")
(b) Address of Principal (For BAC and BANTSA)
Business Offices: 555 California Street
San Francisco, CA 94104
(For BAV and BAVPII) 950 Tower Lane,
Suite 700 Foster City, CA 94404
(c) Citizenship: BAC is organized under the laws of
Delaware. BANTSA is a national
banking association organized under
the laws of the United States. BAV
is organized under the laws of
California. BAVPII is organized
under the laws of Delaware.
(d) Title of Class of Common Stock
Securities:
(e) CUSIP Number: 126667104
Item 3 If this statement is filed pursuant to Rules 13d-1(b) or
13d-2(b), check whether the person filing is a*:
(a) [_] Broker or Dealer registered under Section 15 of the Act
- ----------------
* This filing is being made primarily under Rule 13d-1(c) reporting BAV's and
BAVPII's beneficial ownership. As to shares acquired by BANTSA, this filing
is also being made pursuant to Rules 13d-1(b) and 13d-2(b).
Page 6
<PAGE>
(b) [X] Bank as defined in Section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in Section 3(a)(19)
of the Act
(d) [ ] Investment Company registered under Section 8 of
the Investment Company Act
(e) [ ] Investment Adviser registered under Section 203 of
the Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee Retirement
Income Security Act of 1974 or Endowment Fund; see
ss.240.13d-1(b)(1)(ii)(F)
(g) [X] Parent Holding Company, in accordance with
ss.240.13d-1(b)(ii)(G) (Note: See Item 7)
(h) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(H)
<TABLE>
<CAPTION>
Item 4 Ownership**
<C> <S> <C>
(a) Amount Beneficially Owned:
BAC 380,998
BANTSA 380,998
BAV 304,686
BAVPII 30,468
(b) Percent of Class:
BAC 4.5%
BANTSA 4.5%
BAV 3.6%
BAVPII .4%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote:
BAC 0
BANTSA 0
</TABLE>
- --------------------
** By virtue of the corporate relationships between Reporting Persons as
described in Item 7, BAC (the parent company) may be deemed to possess
indirect beneficial ownership of shares beneficially owned directly by its
subsidiaries. Similarly, higher tier BAC subsidiaries may be deemed to
possess indirect beneficial ownership of shares beneficially owned directly
by lower tier BAC subsidiaries. The power to vote and to dispose of shares
may be deemed to be shared between entities due to their corporate
relationships.
Page 7
<PAGE>
<TABLE>
<S> <C>
BAV 0
BAVPII 0
(ii) shared power to vote or direct the
vote:
BAC 380,998
BANTSA 380,998
BAV 304,686
BAVPII 30,468
(iii) sole power to dispose or direct the
disposition of:
BAC 0
BANTSA 0
BAV 0
BAVPII 0
(iv) shared power to dispose or direct the
disposition of:
BAC 304,686
BANTSA 304,686
BAV 304,686
BAVPII 30,468
</TABLE>
Item 5 Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following [X].
Item 6 Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7 Identification and Classification of the Subsidiaries Which Acquired
the Security Being Reported on by the Parent Holding Company.
Page 8
<PAGE>
See Item 2. Except for BAVPII and BAVPII's individual partners, the
entities described below are direct or indirect wholly-owned
subsidiaries of BAC, which is a registered bank holding company.
BANTSA is a bank as defined in Section 3(a)(6) of the Act. BAV and
BAVPII are filing this statement under Rule 13d-1(c). BAV is a
corporation and is the BAC subsidiary that held the direct
investment in the issuer. BAVPII is a partnership that is related to
BAV.
The partners of BAVPII include: James D. Murphy, a general partner,
residing in the state of California; Jess Marzak, a general partner,
residing in the state of California; Anchie Kuo, a general partner,
residing in the state of California; Robert Obuch, a general
partner, residing in the state of California; and Rory O'Driscoll, a
general partner, residing in the state of California. By virtue of
these individuals being partners of BAVPII, they may each be deemed
to indirectly beneficially own the ownership interest of the Issuer
held by BAVPII. Similarly the partners may be deemed to share voting
and/or investment power among themselves and with BAVPII in the
Issuer through BAVPII. Each partner disclaims beneficial ownership
of all shares of common stock owned by BAVPII.
Item 8 Identification and Classification of Members of the Group.
See Item 7.
Item 9 Notice of Dissolution of Group.
Not Applicable.
Page 9
<PAGE>
Item 10 Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose of
and do not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in connection
with or as a participant in any transaction having such purposes or
effect.
Page 10
<PAGE>
Signature
- ---------
After reasonable inquiry and to the best of my knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: February 9, 1998
BANKAMERICA CORPORATION*
BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION*
BANKAMERICA VENTURES*
*By: /s/ VENRICE R. PALMER
Venrice R. Palmer
Senior Counsel of
Bank of America National Trust and Savings Association and Authorized
Attorney-in-Fact (signing resolutions and powers of attorney are
incorporated by reference to Schedule 13G Amendment #2 relating to Anaren
Microwave, Inc.)
Date: February 9, 1998
BA VENTURE PARTNERS II
By: /s/ Anchie Kuo
-------------------------
Anchie Kuo
Its: General Partner
Page 11
<PAGE>
EXHIBIT A
---------
Joint Filing Agreement
----------------------
The undersigned hereby agree that they are filing this statement jointly
pursuant to Rule 13d-1(f)(1). Each of them is responsible for the timely filing
of such Schedule 13G and any amendments thereto, and for the completeness and
accuracy of the information concerning such person contained therein; but none
of them is responsible for the completeness or accuracy of the information
concerning the other persons making the filing, unless such person knows or has
reason to believe that such information is inaccurate.
Date: February 9, 1998
BANKAMERICA CORPORATION*
BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION*
BANKAMERICA VENTURES*
*By: /s/ VENRICE R. PALMER
Venrice R. Palmer
Senior Counsel of
Bank of America National Trust and Savings Association and Authorized
Attorney-in-Fact (signing resolutions and powers of attorney are
incorporated by reference to Schedule 13G Amendment #2 relating to
Anaren Microwave, Inc.)
Date: February 9, 1998
BA VENTURE PARTNERS II
By: /s/ Anchie Kuo
--------------------------
Anchie Kuo
Its: General Partner
Page 12
